Cyclopharm (ASX:CYC) announces the first signed U.S. contract for Technegas with Duke University Hospital following approval of by the USFDA on 29 September 2023 | ASX Announcement: https://announcements.asx.com.au/asxpdf/20231205/pdf/05y66m6jl37slv.pdf #CYC #USA #Technegas #shorts
MRD
0.032
540%
WYX
0.043
-36.8%
8IH
0.031
181.8%
GLA
0.024
-33.3%
MOM
0.002
100%
EZZ
2.25
-32.2%
RWL
0.225
55.2%
MYX
4.25
-30.4%
AMS
0.022
46.7%
LRD
0.02
-28.6%
BOC
1.46
46%
CNJ
0.008
-27.3%
ARV
0.01
42.9%
LRM
0.032
-27.3%
FRX
0.01
42.9%
TG6
0.205
-26.8%
NYR
0.81
39.7%
POL
0.92
-26.1%
ASH
0.22
37.5%
1AD
0.003
-25%
CNQ
0.555
33.7%
CCO
0.003
-25%
BIT
0.004
33.3%
DTR
0.285
-25%
FLC
0.125
33%
ARU
0.285
-24%
IKE
1.125
31.6%
SQX
0.145
-23.7%
BEL
0.026
30%
I88
0.38
-23.2%
SHO
0.04
29%
MDI
0.03
-23.1%
WBE
0.009
28.6%
YAR
0.01
-23.1%
MFD
0.465
27.4%
HRZ
0.054
-22.9%
DEV
0.14
27.3%
TMS
0.007
-22.2%
MDR
0.028
27.3%
LSR
0.032
-22%
